Claudin-18 splice variant 2 is a pan-cancer target suitable for therapeutic antibody development (Q45401730)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Claudin-18 splice variant 2 is a pan-cancer target suitable for therapeutic antibody development |
scientific article |
Statements
1 reference
Claudin-18 splice variant 2 is a pan-cancer target suitable for therapeutic antibody development (English)
1 reference
1 reference
Christoph Huber
1 reference
Ozlem Türeci
1 reference
Michael Koslowski
1 reference
Dirk Usener
1 reference
Karl Dhaene
1 reference
Gunda Brandenburg
1 reference
Gerhard Seitz
1 reference
1 December 2008
1 reference
1 reference
14
1 reference
23
1 reference
7624-7634
1 reference
Identifiers
1 reference
1 reference